Page last updated: 2024-09-05

sorafenib and amg 925

sorafenib has been researched along with amg 925 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(amg 925)
Trials
(amg 925)
Recent Studies (post-2010) (amg 925)
6,5207305,25110010

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)amg 925 (IC50)
Cyclin-dependent kinase 1Homo sapiens (human)2.22
Cyclin-dependent kinase 4Homo sapiens (human)0.0097
G2/mitotic-specific cyclin-B1Homo sapiens (human)2.22
G1/S-specific cyclin-D1Homo sapiens (human)0.003
Cyclin-dependent kinase 2Homo sapiens (human)0.375
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.002
Cyclin-dependent kinase 6Homo sapiens (human)0.008

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alba, GQ; Ayres, M; Carlson, TJ; Chen, A; Chen, X; Cho, R; Connors, RV; Dai, K; DeGraffenreid, M; Deignan, JT; Duquette, J; Eksterowicz, J; Fan, P; Fisher, B; Fu, J; Gribble, MW; Huard, JN; Kaizerman, J; Kamb, A; Keegan, KS; Li, C; Li, K; Li, Y; Li, Z; Liang, L; Liu, W; Lively, SE; Lo, MC; Ma, J; McGee, LR; McMinn, DL; Medina, JC; Mihalic, JT; Modi, K; Ngo, R; Pattabiraman, K; Piper, DE; Queva, C; Ragains, ML; Suchomel, J; Thibault, S; Walker, N; Wang, X; Wang, Z; Wanska, M; Wehn, PM; Weidner, MF; Wickramasinghe, D; Zhang, AJ; Zhao, X1

Other Studies

1 other study(ies) available for sorafenib and amg 925

ArticleYear
Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3.
    Journal of medicinal chemistry, 2014, Apr-24, Volume: 57, Issue:8

    Topics: Animals; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dogs; Drug Discovery; fms-Like Tyrosine Kinase 3; Heterocyclic Compounds, 3-Ring; Humans; Macaca fascicularis; Naphthyridines; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship; U937 Cells

2014